- Home
- OBIO vs ALAR Comparison
OBIO vs ALAR Comparison
Compare OBIO & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- ALAR
- Stock Information
- Founded
- OBIO 2017
- ALAR 2013
- Country
- OBIO United States
- ALAR Israel
- Employees
- OBIO N/A
- ALAR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- ALAR Computer Software: Prepackaged Software
- Sector
- OBIO Health Care
- ALAR Technology
- Exchange
- OBIO Nasdaq
- ALAR Nasdaq
- Market Cap
- OBIO 118.8M
- ALAR 45.3M
- IPO Year
- OBIO N/A
- ALAR 2018
- Fundamental
- Price
- OBIO $2.86
- ALAR $13.75
- Analyst Decision
- OBIO Strong Buy
- ALAR Strong Buy
- Analyst Count
- OBIO 5
- ALAR 1
- Target Price
- OBIO $14.20
- ALAR $15.00
- AVG Volume (30 Days)
- OBIO 380.0K
- ALAR 264.0K
- Earning Date
- OBIO 08-11-2025
- ALAR 08-25-2025
- Dividend Yield
- OBIO N/A
- ALAR N/A
- EPS Growth
- OBIO N/A
- ALAR N/A
- EPS
- OBIO N/A
- ALAR 0.07
- Revenue
- OBIO $2,886,000.00
- ALAR $30,581,000.00
- Revenue This Year
- OBIO $20.47
- ALAR N/A
- Revenue Next Year
- OBIO $11.45
- ALAR $12.28
- P/E Ratio
- OBIO N/A
- ALAR $20.34
- Revenue Growth
- OBIO 30.23
- ALAR 4.67
- 52 Week Low
- OBIO $2.37
- ALAR $5.45
- 52 Week High
- OBIO $8.87
- ALAR $46.00
- Technical
- Relative Strength Index (RSI)
- OBIO 49.03
- ALAR 64.18
- Support Level
- OBIO $2.78
- ALAR $13.20
- Resistance Level
- OBIO $2.94
- ALAR $14.63
- Average True Range (ATR)
- OBIO 0.23
- ALAR 0.95
- MACD
- OBIO -0.02
- ALAR -0.03
- Stochastic Oscillator
- OBIO 42.86
- ALAR 70.10
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.